At Emirates Hospitals Dubai our expert team of Endocrinologists, Internal Medicine Experts and Family Medicine Doctors are highly experienced in the assessment and treatment options of type 2 diabetes and weight loss in which in some instances may include the recommendation of Ozempic Injections.
Ozempic is medication primarily used as part of treatment plans for type 2 diabetes in adults. It is a medication that contains the active ingredient semaglutide, which belongs to the class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists.
In addition to its glucose-lowering effects, Ozempic has been associated with other beneficial outcomes, such as weight loss, which can be particularly helpful for individuals with type 2 diabetes who are overweight or obese.
As a GLP-1 receptor agonist, Ozempic works by mimicking the action of the naturally occurring hormone GLP-1 in the body. GLP-1 is responsible for stimulating insulin release from the pancreas, reducing glucagon secretion (a hormone that increases blood sugar levels), slowing down stomach emptying, and promoting a feeling of fullness after meals. By enhancing these effects, Ozempic helps to lower blood sugar levels in individuals with type 2 diabetes.
Ozempic is administered once a week as a subcutaneous injection, typically given into the fatty tissue of the abdomen, thigh, or upper arm. It comes in a pre-filled pen device, making self-administration relatively simple. The pen delivers a fixed dose.
Your dosage regime will be determined by our Doctor and it’s essential you follow your prescribed dosage.
At Emirates Hospitals Group, our Endocrinologists are experts in assessing and consulting on the appropriate use of Mounjaro Injection. Mounjaro is considered a game-changer in the treatment of type 2 diabetes in adults. Although in the press it has gained popularity regarding weight-loss, it’s important to note that it is not approved for weight-loss by the FDA.
Please complete the details and we will book you shortly.